Refine Search
(6)
(13)
(72)
(210)

Oncology

GlobalData provides unique and market-leading data and insights into the oncology market. Browse or search our Report Store for the latest comprehensive reports, market data, analysis and survey findings alongside industry information on key companies, markets and financial deals.

Ovarian Cancer: Epidemiology Forecast to 2028

  • $3,995
  • July 2019
Add to Basket Quick View Add to Saved List

Ovarian cancer is the most lethal gynecologic cancer and overall a leading cause of cancer incidence and mortality worldwide. The disease is defined as uncontrolled cell growth in the ovaries, although research has shown that the disease may ac...

B-Cell Non-Hodgkin’s Lymphoma (NHL): Opportunity Analysis and Forecasts to 2027

  • $10,995
  • June 2019
Add to Basket Quick View Add to Saved List

Non-Hodgkin’s lymphoma (NHL) comprises a heterogeneous group of proliferative malignancies that arise in the B cells, T cells, or natural killer (NK) cells within the lymphoid tissue, such as the lymph nodes, bone marrow, thymus, and spleen. B-...

B-Cell Non-Hodgkin’s Lymphoma: Epidemiology Forecast to 2027

  • $3,995
  • June 2019
Add to Basket Quick View Add to Saved List

Non-Hodgkin’s lymphoma (NHL) refers to a group of cancers that develop in the lymphatic system. In NHL, the patient’s immune system is affected by the uncontrollable growth of malignant white blood cells, resulting in the body’s inability to fi...

Duodenal Cancer Global Clinical Trials Review, H1, 2019

  • $2,500
  • May 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Duodenal Cancer Global Clinical Trials Review, H1, 2019" provides an overview of Duodenal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Duode...

Endometrial Cancer Global Clinical Trials Review, H1, 2019

  • $2,500
  • May 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Endometrial Cancer Global Clinical Trials Review, H1, 2019" provides an overview of Endometrial Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on...

Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H1, 2019

  • $2,500
  • May 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H1, 2019" provides an overview of Diffuse Large B-Cell Lymphoma clinical trials scenario. This report provides top line data relating to ...

Colon Cancer Global Clinical Trials Review, H1, 2019

  • $2,500
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Colon Cancer Global Clinical Trials Review, H1, 2019" provides an overview of Colon Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Colon Cance...

Cutaneous B-Cell Lymphoma Global Clinical Trials Review, H1, 2019

  • $2,500
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Cutaneous B-Cell Lymphoma Global Clinical Trials Review, H1, 2019" provides an overview of Cutaneous B-Cell Lymphoma clinical trials scenario. This report provides top line data relating to the clin...

Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2019

  • $2,500
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2019" provides an overview of Cutaneous T-Cell Lymphoma clinical trials scenario. This report provides top line data relating to the clin...

Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2019

  • $2,500
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2019" provides an overview of Chronic Lymphocytic Leukemia (CLL) clinical trials scenario. This report provides top line data re...

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2019

  • $2,500
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2019" provides an overview of Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) clinical tria...

Multiple Myeloma: Epidemiology Forecast to 2027

  • $3,995
  • March 2019
Add to Basket Quick View Add to Saved List

Multiple myeloma (MM) (International Statistical Classification of Diseases and Related Health Problems, 10th Revision [ICD-10] code = C90.0) is a hematologic cancer that forms in a type of white blood cell called a plasma cell.

In 2017, ...

Multiple Myeloma: Global Drug Forecast and Market Analysis to 2027

  • $10,995
  • March 2019
Add to Basket Quick View Add to Saved List

Multiple myeloma (MM) is a cancer of abnormal plasma cells, a type of white blood cell that is normally responsible for producing antibodies in the bone marrow. It is the second most common hematological malignancy in the US, and constitutes le...

Brain Cancer Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Brain Cancer Global Clinical Trials Review, H2, 2018" provides an overview of Brain Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Brain Cance...

Brenner Tumor Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Brenner Tumor Global Clinical Trials Review, H2, 2018" provides an overview of Brenner Tumor clinical trials scenario. This report provides top line data relating to the clinical trials on Brenner T...

Join our mailing list
Find out first about the latest reports and offers.